Recruiting Breast Cancer Studies in Golden
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
This phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men with breast cancer whos...
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)...
About Breast Cancer Clinical Trials in Golden
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Golden, CO. These studies are seeking a combined 580 participants. Research is being sponsored by Olema Pharmaceuticals, Inc., Criterium, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Golden — FAQ
Are there breast cancer clinical trials in Golden?
Yes, there are 2 breast cancer clinical trials currently recruiting in Golden, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Golden?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Golden research site will contact you about next steps.
Are clinical trials in Golden free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Golden studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Golden are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov